MedPath

Escitalopram Oxalate

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ESCITALOPRAM ORAL SOLUTION safely and effectively. See full prescribing information for ESCITALOPRAM ORAL SOLUTION. ESCITALOPRAM Oral Solution Initial U.S. Approval: 2002

Approved
Approval ID

82d793ee-4039-45fc-ac83-4bd5235f00aa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 20, 2023

Manufacturers
FDA

Camber Pharmaceuticals, Inc.

DUNS: 826774775

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Escitalopram Oxalate

PRODUCT DETAILS

NDC Product Code31722-569
Application NumberANDA202221
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 20, 2023
Generic NameEscitalopram Oxalate

INGREDIENTS (11)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
MALIC ACIDInactive
Code: 817L1N4CKP
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PEPPERMINTInactive
Code: V95R5KMY2B
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
ESCITALOPRAM OXALATEActive
Quantity: 5 mg in 5 mL
Code: 5U85DBW7LO
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Escitalopram Oxalate - FDA Drug Approval Details